KESTRA MEDICAL TECHNOLOGIES, LTD.
For the period ended Jan 31, 2025. Filed Apr 17, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jan 31, 2025 · Filed Apr 17, 2025
KMTS$29.55-1.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Condensed Consolidated Balance Sheets
CONDENSED CONSOLIDATED BALANCE SHEETS
| January 31, 2025 | April 30, 2024 | |
|---|---|---|
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $54,352 | $8,249 |
| Accounts receivable, net | 7,929 | 1,998 |
| Disposable medical equipment supplies | 5,999 | 3,290 |
| Prepaid expenses and other current assets | 1,636 | 1,370 |
| Total current assets | 69,916 | 14,907 |
| Right-of-use assets | 1,956 | 2,286 |
| Deposits | 2,058 | 1,710 |
| Restricted cash | 334 | 334 |
| Property and equipment, net | 31,387 | 26,105 |
| Other long-term assets | 2,344 | 607 |
| Total assets | $107,995 | $45,949 |
| Liabilities, Redeemable Preferred Stock and Stockholder’s Deficit | ||
| Current liabilities | ||
| Accounts payable | $25,657 | $23,892 |
| Accrued liabilities | 13,036 | 9,079 |
| Total current liabilities | 38,693 | 32,971 |
| Operating lease liabilities, net of current portion | 2,862 | 2,633 |
| Other long-term liabilities | 76 | 76 |
| Long-term debt, net | 43,749 | 42,536 |
| Total liabilities | 85,380 | 78,216 |
| Commitments and contingencies (Note 14) | ||
| Redeemable preferred stock, $0.01 par value; 5,000,000 shares authorized; 280,510 and 177,110 shares issued and outstanding as of January 31, 2025 and April 30, 2024, respectively | 280,510 | 177,110 |
| Stockholder’s deficit | ||
| Common stock, $0.01 par value; 5,000,000 shares authorized; 105,808 shares issued and outstanding | 1 | 1 |
| Additional paid-in capital | 194,142 | 197,057 |
| Accumulated deficit | (468,196) | (406,435) |
| Total West Affum Intermediate Holdings Corp. stockholder’s deficit | (274,053) | (209,377) |
| Non-controlling interest | 16,158 | — |
| Total stockholder’s deficit | (257,895) | (209,377) |
| Total liabilities and stockholder’s deficit | $107,995 | $45,949 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.